Physician
Urology
Dr. Kent K. Teruya, MD
|
|
Give Review
Kent K. Teruya is an expert in the field of Urology. He attended Creighton University School of Medicine. Creighton University School of Medicine is ranked 79/78 in Research/PrimaryCare. Kent K. Teruya, MD is also published. He has 35 publications published. The lastest publication: "Association between duration of obesity and risk of non-insulin-dependent diabetes mellitus. The Sotetsu Study.' He is registered with Medicare and accepts Medicare payments.
Publications
- Establishment of hybridomas producing cancer Specific human antibodies from B cell line derived from PBL of a patient with adult T cell leukemia.
- Epitope analysis of human monoclonal antibody Specific for rice allergenic protein generated by in vitro immunization.
- Availability of oncogene activated production system for mass production of light chain of human antibody in CHO cells.
- Changes of monosaccharide availability of human hybridoma lead to alteration of biological properties of human monoclonal antibody.
- Enhancement of interferon-beta production with sphingomyelin from fermented milk.
- Modified Antigen-binding of human antibodies with glycosylation variations of the light chains produced in sugar-limited human hybridoma cultures.
- Cell hybridization, hybridomas, and human hybridomas.
- Induction of basophilic and eosinophilic differentiation in the human leukemic cell line KU812.
- Relationship between weight change in young adulthood and the risk of NIDDM. The Sotetsu Study.
- Association between duration of obesity and risk of non-insulin-dependent diabetes mellitus. The Sotetsu Study.
- Prevalence and risk factors of allergic rhinitis and cedar pollinosis among Japanese men.
- Improved segmental isotope labeling of proteins and application to a larger protein.
- Production of recombinant human monoclonal antibody using ras-amplified BHK-21 cells in a protein-free medium.
- Ras oncogene enhances the production of a recombinant protein regulated by the cytomegalovirus promoter in BHK-21 cells.
- E1A and ras oncogenes synergistically enhance recombinant protein production under control of the cytomegalovirus promoter in BHK-21 cells.
- Ras amplification in BHK-21 cells produces a host cell line for further rapid establishment of recombinant protein hyper-producing cell lines.
- Secretory cell immunoscreening assay--a highly sensitive screening method for secretory cells.
- Polypeptide synthesis using an expressed peptide as a building block for condensation with a peptide thioester: application to the synthesis of phosphorylated p21Max p...
- Site-Specific isotope labeling of long RNA for structural and mechanistic studies.
- Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors.
- Binding and selectivity of the marine toxin neodysiherbaine A and its synthetic analogues to GluK1 and GluK2 kainate receptors.
- Evaluation of superior BACE1 cleavage sequences containing unnatural amino acids.
- Semisynthesis of a protein with cholesterol at the C-terminal, targeted to the cell membrane of live cells.
- GABAA receptor subunit beta1 is involved in the formation of protease-resistant prion protein in prion-infected neuroblastoma cells.
- Heterozygous inhibition in prion Infection: the stone fence model.
- Amyloidophilic compounds for prion Diseases.
- Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease Infection.
- Antiprion activity of functionalized 9-aminoacridines related to quinacrine.
- Conformational change in hamster scrapie prion protein (PrP27-30) associated with proteinase K resistance and prion infectivity.
- Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion Diseases in a prion strain-depe...
- Evaluations of substrate Specificity and inhibition at PR/p3 cleavage site of HTLV-1 protease.
- Solid-phase syntheses of olefin-containing inhibitors for HTLV-1 protease using the Horner-Emmons reaction.
- Fmoc-based chemical synthesis and selective binding to supercoiled DNA of the p53 C-terminal segment and its phosphorylated and acetylated derivatives.
- Solid-phase synthesis of HTLV-1 protease inhibitors containing hydroxyethylamine dipeptide isostere.
Schools
Creighton University
Creighton University Affil Hospital
Conditions Treated
- Bladder Infection
- Bladder Stones
- Blood in Urine (Hematuria)
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Urology
Accepted Insurances
Education
-
Creighton University -
Creighton University School of Medicine
Drug Facts
| NPI NUMBER | 1093812091 | |
| NPPES Provider LastName | TERUYA | |
| NPPES Provider FirstName | KENT | |
| NPPES Provider ZIPCode | 968132412 | |
| NPPES Provider State | HI | |
| Specialty Description | Urology | |
| Total Claim Count | 744.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1093812091 |
| Last Name Of The Provider | TERUYA |
| First Name Of The Provider | KENT |
| View All |
Similar Doctors
|
|
Dr. Steven J. Berman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ulrich Stams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael D. Uechi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert G. Carlile, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randal A. Aaberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Garry B. Peers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randall C. Blake, MD
This Doctor is OpenDoctor Recommended.
|